Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Targeted Microbiome is a biotechnology company focused on developing precision microbial therapies to treat a variety of human diseases. The company leverages a proprietary platform to identify and engineer specific microbial strains that can modulate the gut microbiome and restore healthy biological function. Their current research efforts are primarily directed toward infectious diseases and inflammatory conditions where the microbiome plays a critical role in pathogenesis. By utilizing a targeted approach, the company aims to provide more effective and safer alternatives to broad-spectrum antibiotics and systemic immunosuppressants.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Targeted Microbiome.